Biocon Biologics to present at 43rd Annual JP Morgan Healthcare Conference Ruchika Sharma10 Jan 2025 1:30 PM ISTKarnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, will present at the 43rd Annual J.P....
Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
USFDA issues EIR for Biocon Bengaluru facility Ruchika Sharma25 Dec 2024 12:53 PM ISTBengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and...
Biocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug in EU Ruchika Sharma24 Dec 2024 11:36 AM ISTBangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex...
Biocon Chief Kiran Mazumdar-Shaw conferred Jamsetji Tata Award by Indian Society for Quality Ruchika Sharma16 Dec 2024 10:00 AM ISTBengaluru: Biocon Group Chairperson Kiran Mazumdar-Shaw has been conferred the prestigious Jamsetji Tata Award by the Indian Society for Quality...
Biocon Chief Kiran Mazumdar Shaw condoles former Karnataka CM S M Krishna death Ruchika Sharma13 Dec 2024 12:54 PM ISTBengaluru: Kiran Mazumdar-Shaw, the Executive Chairperson of Biocon Limited, expressed her condolences on the passing of former Karnataka Chief...
Biocon sells 80 lacs equity shares of Syngene International for Rs 686 crores Ruchika Sharma12 Dec 2024 5:06 PM ISTBangalore: Biocon has sold Eighty Lacs equity shares of Syngene International Limited for Rs. 686 crores. The transacted value is the gross...
Biocon Biologics recognized as Asia IP Elite for 2024 by IAM Ruchika Sharma12 Dec 2024 12:39 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced that it has once again been recognized as an Asia IP Elite for...
Biocon gets EIR with VAI status from USFDA for Bengaluru API facility Ruchika Sharma9 Dec 2024 11:30 AM ISTBangalore: In a recent BSE filing, Biocon has informed that the U.S. Food and Drug Administration (US FDA) has issued an Establishment...
USFDA classifies Biocon Biologics Biocon Park Site in Bengaluru as VAI Ruchika Sharma11 Nov 2024 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' facilities at Biocon Park,...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
Biocon gets 4 USFDA observations for Bengaluru facility Ruchika Sharma30 Sept 2024 6:45 PM ISTBangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...
